BP002317-PRO-477: Recombinant Human Hypoxia-Inducible Factor-1 Alpha (HIF1A) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP002588-ENZ-210: Recombinant Human Histone Deacetylase 8 (HDAC8) Enzyme
Source: E. coli-derived.
Purity: > 80% as determined by SDS-PAGE.BP002587-ENZ-157: Recombinant Human Histone Deacetylase 2 (HDAC2) Enzyme
Source: Hi-5 Cell-derived.
Purity: > 85% as determined by SDS-PAGE.BP002840-HCV-200: Recombinant Hepatitis C Virus NS4 a+b, Biotin
Source: E. coli-derived.
Purity > 95% as determined by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP002840-HCV-264: Recombinant Hepatitis C Virus NS4 a+b
Source: E. coli-derived.
Purity > 95% as determined by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP002840-HCV-202: Recombinant Hepatitis C Virus NS4 (1916-1947 a.a.)
Source: E. coli-derived.
Purity > 95% as determined by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP002840-HCV-268: Recombinant Hepatitis C Virus NS4 a+b, Fluoroscein
Source: E. coli-derived.
Purity > 95% as determined by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP002840-HCV-226: Recombinant Hepatitis C Virus NS4 a+b Rhodamine Labeled
Source: E. coli-derived.
Purity > 95% as determined by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WBBP002839-HCV-267: Recombinant Hepatitis C Virus NS3, His Tag
Source: E. coli-derived.
Purity > 95% as determined by SDS-PAGE.BP002839-HCV-255: Recombinant Hepatitis C Virus NS3 (1450-1643 a.a.)
Source: E. coli-derived.
Purity > 95% as determined by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.